New Data for Genentech's Vabysmo Reinforce Its Efficacy, Safety and Durability in Wet Age-Related Macular Degeneration (AMD)
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today new data from the AVONELLE-X and SALWEEN studies of Vabysmo® (fari...
AMD: No Longer A No-Brainer But Still A Buy
AMD's Q2 results were mixed, with strong overall revenue but notable data center and EPS weakness due to export restrictions. Adoption of AMD's GPUs is progressing, and recent export approvals for ...
PulseSight Therapeutics Provides New Insights into the Role of Iron and Transferrin in AMD, Supporting its PST-611 Vectorized Therapy for Dry AMD/G...
PARIS, Sept. 04, 2025 (GLOBE NEWSWIRE) -- PulseSight Therapeutics, an ophthalmology biotech company developing disruptive non-viral vectorized therapies with minimally-invasive delivery technology ...
AMD: Nvidia Signals Lasting AI Boom
Advanced Micro Devices, Inc.'s AI chip demand is set to surge, regardless of unresolved China issues. The company's MI355 and upcoming MI400 GPUs position AMD to capture significant AI inference ma...
AMD Rides on Accelerating Data Center Growth: A Sign of More Upside?
AMD's surging EPYC adoption, cloud wins, and Instinct GPU traction fuel strong Data Center growth despite AI export headwinds.
Why this analyst says skip Nvidia but play these 3 chip stocks
Semiconductors are driving the future of tech, but which companies are worth watching other than Nvidia (NVDA)? Ali Mogharabi, senior equity analyst at WestEnd Capital Management, discusses his top...
3 Red-Hot Growth Stocks to Buy in 2025
The hottest area of growth in the market is artificial intelligence (AI). This is being led by big tech companies, which continue to see strong demand stemming from AI.
AMD's AI Journey Rides on Strong Partner Base: What's the Path Ahead?
AMD's expanding partner base, strong EPYC demand, and new AI collaborations fuel growth despite stiff competition from NVIDIA and Broadcom.
AMD: There Is Still Time To Accumulate Shares
I reiterate my Strong Buy rating for Advanced Micro Devices, Inc., as the market is finally recognizing its AI potential and undervalued stock price. AMD's AI accelerators and EPYC CPUs are gaining...
A Look At Nvidia And AMD's $3 Billion Export “Tax” Deal With Trump
Two of the largest companies in the world, Nvidia and AMD, have agreed to pay the U.S. 15% of their revenues from sales of chips and semiconductors to China. This agreement can be viewed as a win-w...
AMD to Host Financial Analyst Day on November 11, 2025
SANTA CLARA, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- AMD (NASDAQ: AMD) announced it will host its 2025 Financial Analyst Day on Tuesday, Nov. 11, 2025, in New York City. The event will feature pr...
AMD: Way Too Early To Take Profits Now
Advanced Micro Devices, Inc. has staged an incredible comeback, driven by robust Q2 results and momentum in its data center CPU and AI chip businesses. Despite cyclical volatility in Client and Gam...
AMD Q2: Continued Growth Acceleration Supports Multiple Rerating
Advanced Micro Devices, Inc.'s Q2 FY2025 earnings were mixed due to an $800 million MI308 inventory write-off, with revenue beating estimates while non-GAAP EPS came in line. Q3 FY2025 guidance cam...
Nvidia and AMD cut a chip revenue-sharing deal with Trump. Here's how their stock prices are reacting
In a historically unusual move, two of the world's largest chipmakers, Nvidia and Advanced Micro Devices (AMD), have reportedly cut a deal with the Trump administration to hand over 15% of their re...
Nvidia-AMD export deal could shake up global supply chains, analysts say
Nvidia Corp (NASDAQ:NVDA, ETR:NVD) and Advanced Micro Devices Inc (NASDAQ:AMD, ETR:AMD)'s new deal to hand over 15% of their chip sales revenue in China to the US government is a game-changer that ...
Related Companies